Infectious Diseases Institute
Goal: To build capacity in Africa for the delivery of sustainable, high quality care and prevention of HIV/AIDS and related infectious diseases through training and research
Targeted Area: Sub-Saharan Africa, centered in Uganda
Start Date: 2001
Pfizer's Commitment: Support for the building of a regional treatment, research and training institute in Kampala, Uganda to strengthen local and regional capacity in HIV/AIDS care
Partners: Makerere University, Accordia Global Health Foundation, the Infectious Diseases Society of America and The AIDS Support Organization (TASO) among others
Successes:
- Trained more than 3,500 health care providers from 27 African countries
- Currently providing care to approximately 10,000 patients
- Building research capacity in Africa by pairing promising new investigators with established researchers from North America and Europe, and through mentoring arrangements and fellowships
- Infectious Diseases Institute fact sheet
- View the 2007 Accordia Global Health Foundation Annual Report
Visit the Academic Alliance Foundation Web Site.
Visit the Infectious Diseases Institute Web Site
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Privacy Policy
Copyright © 2002–2010 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
